Cargando…
Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment
Glioblastoma multiforme is a lethal disease and represents the most common and severe type of glioma. Drug resistance and the evasion of cell death are the main characteristics of its malignancy, leading to a high percentage of disease recurrence and the patients’ low survival rate. Exploiting the m...
Autores principales: | de Souza, Izadora, Ramalho, Maria Carolina Clares, Guedes, Camila Banca, Osawa, Isabeli Yumi Araújo, Monteiro, Linda Karolynne Seregni, Gomes, Luciana Rodrigues, Rocha, Clarissa Ribeiro Reily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266903/ https://www.ncbi.nlm.nih.gov/pubmed/35805884 http://dx.doi.org/10.3390/ijms23136879 |
Ejemplares similares
-
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
por: Almeida Lima, Karoline, et al.
Publicado: (2023) -
Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
por: Ribeiro Reily Rocha, Clarissa, et al.
Publicado: (2020) -
The Role of Chaperone-Mediated Autophagy in Cell Cycle Control and Its Implications in Cancer
por: Andrade-Tomaz, Marina, et al.
Publicado: (2020) -
High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation
por: de Souza, I., et al.
Publicado: (2022) -
ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation
por: Gomes, Luciana Rodrigues, et al.
Publicado: (2019)